Eli Lilly & Co (LLY) SEC Filings — 2024

Filings

• Eli Lilly Elects New Directors, Adjusts Officer Compensation — 8-K · Nov 19, 2024
• Eli Lilly & Co SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Eli Lilly & Co. Files Q3 2024 10-Q Report — 10-Q · Oct 30, 2024
• Eli Lilly & Co SC 13G/A Filing — SC 13G/A · Oct 23, 2024
• Eli Lilly Files 8-K: Director Changes and Compensation Details — 8-K · Sep 9, 2024
• Eli Lilly Files 8-K: Director Changes and Officer Compensation — 8-K · Aug 16, 2024
• Eli Lilly Files 8-K on Debt Issuances — 8-K · Aug 14, 2024
• Eli Lilly Files Q2 2024 10-Q, Details Debt — 10-Q · Aug 8, 2024
• Eli Lilly Announces Executive Compensation Changes — 8-K · Jul 10, 2024
• Eli Lilly Announces Board Changes and Officer Compensation Details — 8-K · Jun 5, 2024
• Eli Lilly Files 8-K on Shareholder Vote Matters — 8-K · May 9, 2024
• Eli Lilly and Company Files 10-Q for Period Ending March 31, 2024 — 10-Q · Apr 30, 2024
• Eli Lilly and Company files DEF 14A for the fiscal year ending December 31, 2023. — DEF 14A · Mar 22, 2024
• Eli Lilly and Company Files 2023 Annual Report on Form 10-K — 10-K · Feb 21, 2024
• Vanguard Amends Eli Lilly Stake, Remains Key Passive Investor — SC 13G/A · Feb 13, 2024
• Eli Lilly Updates Debt Instruments in 8-K Filing — 8-K · Feb 9, 2024
• Eli Lilly Files 8-K on Financial Results & Debt Notes — 8-K · Feb 6, 2024
• BlackRock Amends Eli Lilly Stake, Signals Continued Confidence — SC 13G/A · Jan 29, 2024
• Lilly Endowment Amends Eli Lilly Stake, Passive Ownership Confirmed — SC 13G/A · Jan 26, 2024